2-Picolinic acid
Cat.No:IP3100 Solarbio
CAS:98-98-6
Molecular Formula:C6H5NO2
Molecular Weight:123.11
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
Immunology & Inflammation >
2-Picolinic acidCAS:98-98-6
Molecular Formula:C6H5NO2
Molecular Weight:123.11
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
CAS | 98-98-6 |
Name | 2-Picolinic acid |
Molecular Formula | C6H5NO2 |
Molecular Weight | 123.11 |
Solubility | Soluble in Water/DMSO ≥5mg/mL |
Purity | ≥98% |
Appearance | White to off-white Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
EC | EINECS 202-719-7 |
MDL | MFCD00006293 |
SMILES | O=C(O)C1=CC=CC=N1 |
InChIKey | SIOXPEMLGUPBBT-UHFFFAOYSA-N |
InChI | InChI=1S/C6H5NO2/c8-6(9)5-3-1-2-4-7-5/h1-4H,(H,8,9) |
PubChem CID | 1018 |
Target Point | Others |
Passage | Immunology & Inflammation |
Background | It is an important immunomodulator in plants and humans. |
Biological Activity | PCL 016是一种局部抗病毒药物,兔子中发现能够抑制腺病毒复制。[1] |
Data Literature Source | [1]. E.G. Romanowski,et al. A Novel Topical Antiviral Agent,PCL–016 (Picolinic Acid),Inhibits Adenovirus Replication in the Ad5/NZW Rabbit Ocular Model. ARVO Annual Meeting Abstract. May 2005 Volume 46,Issue 13 |
Unit | Bottle |
Specification | 500mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.